China SXT Pharmaceuticals (SXTC) Intangibles (2018 - 2025)

China SXT Pharmaceuticals' Intangibles history runs 8 years deep, the most recent figure standing at $8532.0 for Q3 2025.

• In Q3 2025, Intangibles fell 46.33% year-over-year to $8532.0; the TTM figure through Sep 2025 stood at $8532.0 (down 46.33% YoY), while the FY2025 annual figure was $11808.0, down 38.18% from the prior year.
• Intangibles was $8532.0 for Q3 2025 at China SXT Pharmaceuticals, down from $11808.0 in the prior quarter.
• In the past five years, Intangibles ranged from a high of $85728.0 in Q1 2022 to a low of $8532.0 in Q3 2025.
• Historically, Intangibles has averaged $34747.4 across 5 years, with a median of $25191.0 in 2023.
• The sharpest annual moves came in 2021 and 2023: Intangibles surged 65.72% in 2021, then plunged 67.49% in 2023.
• A 5-year view of Intangibles shows it stood at $42353.0 in 2021, then retreated by 27.46% to $30724.0 in 2022, then retreated by 26.72% to $22514.0 in 2023, then retreated by 29.39% to $15898.0 in 2024, then tumbled by 46.33% to $8532.0 in 2025.
• The last three Intangibles figures came in at $8532.0 (Q3 2025), $11808.0 (Q1 2025), and $15898.0 (Q3 2024), per Business Quant data.